Ambev S.A. (NYSE:ABEV) traded at $3.00 at close of the session on Tuesday, 09/20/22, made an upward move of 1.35% on its previous day’s price.
Looking at the stock we see that its previous close was $2.96 and the beta (5Y monthly) reads 0.91 with the day’s price range being $2.91 – $3.015. The company has a trailing 12-month PE ratio of 18.40. In terms of its 52-week price range, ABEV has a high of $3.32 and a low of $2.42. The company’s stock has gained about 0.33% over that past 30 days.
Ambev S.A. has a market cap of $48.69 billion. With its Forward Dividend at 0.20 and a yield of 6.67%, the company’s investors could be anxious for the ABEV stock to gain ahead of the earnings release. Estimates by analysts give the company expected earnings per share (EPS) of $0.02, with the EPS growth for the year raised at $0.14 for 2022 and $0.13 for next year. These figures represent -6.70% and -7.10% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $3.36 billion, with a low of $3.14 billion and a high of $3.51 billion. The median projection represents growth squeezing down to 13.30% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2022 is expected to hit $14.51 billion, or 7.50% up from figures reported last year.
There have been 1 upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the ABEV stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 50% Buy.
Based on estimates by 17 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 3 have rated the Ambev S.A. (ABEV) stock as a Hold, while 9 rate it as a Buy. 2 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 3 suggest the stock as a Sell. The stock has an overall rating of Overweight and investors could take advantage and scoop up stock of the company.
Looking further, we note that the PEG ratio for the ABEV stock currently stands at 2.02, and the current price level is 1.51% off its SMA20 and 5.31% from its 50-day simple moving average. The RSI (14) is pointing at 55.77 while the volatility over the past week is 3.04% and jumps to 2.64% over the past one month. The beta value is 1.11, while the average true range (ATR) is currently pointing at 0.08. The average price target for the stock over the next 12 months is $3.66, with the estimates having a low of $2.30 and a high of $5.00. These price ends are 23.33% and -66.67% off the current price level respectively, although investors could be excited at the prospect of a -22.67% if the ABEV share price touches on the median price of $3.68.
Let’s briefly compare Ambev S.A. (ABEV) stock to its peers. We find that current price change of 1.35% and 6.61% over the past 12 months for ABEV competes that of The Boston Beer Company Inc. (SAM), which has seen its stock price rise 1.25% in the last trading session and was -36.59% over the last one year. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial were at -1.13% and -1.01%, respectively, at close of the trading.
Coming back to Ambev S.A. (NYSE:ABEV), we note that the average 3-month trading volume was 30.49 million, while that of the preceding 10-day period stands at 22.15 million. Current shares outstanding are 15.74 billion.
The institutions hold 17.70%. The data shows that short shares as of Jul 14, 2022, stood at 31.73 million at a short ratio of 0.88. This represents a 0.20% short interest in shares outstanding on Jul 14, 2022. Shares short rose in July from the previous month at 30.1 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 7.14% up in year-to-date price movement.